Collaboration to Study CELEXT07 as a Novel
Plant Biostimulant and Biocontrol Agent
MONTREAL, Sept. 23, 2019
/CNW/ - Mondias Natural Products Inc. (TSXV: NHP)
specializing in evidence-based botanical products for the
healthcare and bio-agriculture markets today announces that it has
entered into a Research Agreement with Premier Tech, a
multinational company operating in Horticulture and Agriculture,
Systems and Automation, and Environmental Technologies to conduct
studies on Mondias' CELEXT07 potential as a novel biostimulant and
biopesticide agent. Under the terms of the Exclusive Agreement
dated September 20, 2019, Mondias
will supply quantities of CELEXT07 product material and Premier
Tech will conduct a series of experiments to study various
biological mechanisms with the product. The exclusivity period will
last for 180 days from the initiation of the studies by Premier
Tech. As part of the Agreement and depending on results and
outcomes, Mondias and Premier Tech, will be working in good faith
on commercial terms for CELEXT07.
![Logo: Mondias Natural Products (CNW Group/Mondias Natural Products Inc.) Logo: Mondias Natural Products (CNW Group/Mondias Natural Products Inc.)](https://mma.prnewswire.com/media/999029/Mondias_Natural_Products_Inc__Mondias_Naturals_Signs_Exclusive_R.jpg)
Dr. Patrick Frankham, Mondias CEO
stated that "we are delighted to be working with Premier Tech, a
North American leader in Horticulture and Agriculture, to confirm
that CELEXT07 has potential to significantly increase crop yields
by stimulating growth and increasing plant immunity." Dr. Frankham
also added "previous studies conducted on cannabis plants indicated
that CELEXT07 could be of value in an emerging industry where grey
mould and powdery mildew diseases can impact margins and be a
safety concern for consumers. Therefore, creating a commercial
product and evaluating the business case with the expertise of
Premier Tech is a great opportunity for Mondias."
Mark Murphy, Vice-President
Strategic Development of Premier Tech's Horticulture and
Agriculture Group stated that "we are encouraged by the early
results that CELEXT07 has demonstrated and we welcome the
opportunity to explore further commercial possibilities with the
product and with Mondias Naturals."
CELEXT07 is patent pending on herbal phytosanitary composition
and methods for the prevention and treatment of plant infections in
Australia, Brazil, Canada, China, European Union, and the US and the
World Intellectual Property Organization (WIPO). Mondias has
invested in research programs in collaboration with McGill's
Faculty of Agricultural and Environmental Sciences to develop
CELEXT07.
About Mondias Natural Products Inc.
Mondias
specializes in the commercialization and development of
evidence-based botanical products for the healthcare,
bio-agriculture and organic markets. The company sells both oral
and topical botanical agents to help manage unmet medical needs
through its Holizen Laboratories division. Mondias is also
developing botanical-based specialty fertilizers for use on
household plants, lawns and golf courses and in urban gardens,
nurseries and greenhouses, in collaboration with McGill's Faculty
of Agricultural and Environmental Sciences.
For more information, visit: www.mondias.ca
About Premier Tech
Making a difference, this is what
we are all about at Premier Tech. One team driven by a shared
passion to deliver solutions that will better the lives of people,
businesses and communities. At Premier Tech, People and
Technologies connect in lasting, transformative ways, giving life
to products and services that help feed, protect and improve our
world. We are committed to creating sustainable solutions that help
bring beautiful gardens to life, increase crop yields, improve the
efficiency of manufacturing facilities, treat and recycle water,
and much more as we keep innovating.
For more than 95 years, Premier Tech has been growing
internationally, driven by the collective power of its 4 600 team
members in 27 countries. Backed by a quarter-century-long track
record of solid growth, Premier Tech today records sales of nearly
900 million dollars.
People and Technologies making a difference
For more
information about Premier Tech, visit: www.premiertech.com and
follow twitter.com/_PremierTech
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking statements
Some statements in this
release may contain forward-looking information. All statements,
other than statements of historical fact, that address activities,
events or developments that the Company believes, expects or
anticipates will or may occur in the future (including, without
limitation, statements regarding potential acquisitions and
financings) are forward-looking statements. Forward-looking
statements are generally identifiable by the use of the words
"may", "will", "should", "continue", "expect", "anticipate",
"estimate", "believe", "intend", "plan" or "project" or the
negative of these words or other variations on these words or
comparable terminology. Forward-looking statements are subject to a
number of risks and uncertainties, many of which are beyond the
Company's ability to control or predict, that may cause the actual
results of the Company to differ materially from those discussed in
the forward-looking statements. Factors that could cause actual
results or events to differ materially from current expectations
include the Company's inability to obtain sufficient financing to
execute its business plan; competition; regulation; anticipated and
unanticipated costs and delays; the success of the Company's
research and development strategies; the ability to obtain orphan
drug status; the applicability of the discoveries made; the
successful and timely completion and uncertainties related to the
regulatory approval process; the timing of clinical trials; the
timing and outcomes of regulatory or intellectual property
decisions; and other risks disclosed in the Company's public
disclosure record on file with the relevant securities regulatory
authorities. Although the Company has attempted to identify
important factors that could cause actual results or events to
differ materially from those described in forward-looking
statements, there may be other factors that cause results or events
not to be as anticipated, estimated or intended. Readers should not
place undue reliance on forward-looking statements. The
forward-looking statements in this news release are made as of the
date of this news release, and the Company does not undertake any
obligation to publicly update them to reflect new information or
subsequent events or otherwise except as required by applicable
securities legislation.
SOURCE Mondias Natural Products Inc.